Immunic Therapeutics

Immunic Therapeutics

Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company.

HQ location
New York City, United States
Founding location
Munich, Germany
Website
immunic.de
Launch date
Employees
51-200 people
Enterprise value
$44—66m
https://twitter.com/immunic_aghttps://www.linkedin.com/company/immunic-therapeutics/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor investor investor investor

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
*

$65.0m

Post IPO Equity
Total Funding000k
Bayern Kapital
Bayern Kapital(exited)
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)(exited)
EQT Life Sciences
EQT Life Sciences(exited)
LifeCare Partners
LifeCare Partners(exited)
High-Tech Gründerfonds
High-Tech Gründerfonds(exited)
Soleus Capital
Soleus Capital(exited)
RTW Investments
RTW Investments(exited)
BVF Partners
BVF Partners
Avidity Partners
Avidity Partners(exited)
Adage Capital
Adage Capital(exited)
Janus Henderson Investors
Janus Henderson Investors
Coastland Capital
Coastland Capital
Aberdeen Standard Investments
Aberdeen Standard Investments

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads